Diamedica TherapeuticsDMAC
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 57 institutions reported holding Diamedica Therapeutics Inc. (DMAC) in their 13F filings, up 12 from Q4 2024. 14 opened new positions and 2 sold out. The largest holders were Omega Advisors (Leon Cooperman) ($6.2M), Vanguard Group Inc. ($5.1M) and First Manhattan Co. Llc. ($2.3M). 3 famous investors held it, including Leon Cooperman (0.2% of Omega Advisors (Leon Cooperman)'s portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Diamedica Therapeutics Inc.
- CUSIP
- 25253X207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $718K |
| Exits | 2 | $419K |
All 13F filers, Q4 2024 → Q1 2025: 1,201,328 shares bought and 416,248 shares sold, net +785,080 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 57 holders
| Omega Advisors (Leon Cooperman) | 0.24% | No change | 1,625,000 | $6.2M |
| Vanguard Group Inc. | 0.00% | Add +8.8% | 1,351,467 | $5.1M |
| First Manhattan Co. Llc. | 0.01% | Reduce -27.7% | 606,435 | $2.3M |
| Paragon Associates & Paragon Associates II Joint Venture | 5.33% | Add +16.6% | 600,000 | $2.3M |
| Susquehanna International Group, LLP | 0.00% | Add +48.5% | 556,593 | $2.1M |
| Bleichroeder LP | 0.39% | No change | 382,317 | $1.4M |
| Millennium Management | 0.00% | Add +297.1% | 336,880 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +3.3% | 315,741 | $1.2M |
| Northern Trust Corp. | 0.00% | Reduce -1.6% | 177,280 | $672K |
| LPL Financial LLC | 0.00% | Add +2.2% | 155,300 | $589K |
| Royal Bank of Canada | 0.00% | Add +46879.1% | 155,031 | $588K |
| Goldman Sachs Group Inc. | 0.00% | Add +76.7% | 121,802 | $462K |
| BlackRock, Inc. | 0.00% | Reduce -1.4% | 106,350 | $403K |
| Morgan Stanley | 0.00% | Add +18.5% | 103,583 | $393K |
| Jane Street Group, LLC | 0.00% | Add +138.5% | 100,669 | $382K |
| State Street Corp. | 0.00% | No change | 85,029 | $322K |
| Blue Trust, Inc. | 0.00% | No change | 69,122 | $262K |
| HRT Financial LP | 0.00% | New | 56,703 | $214K |
| Citadel Advisors | 0.00% | Add +233.3% | 53,700 | $204K |
| Catalyst Financial Partners LLC | 0.03% | No change | 38,457 | $146K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -61.0% | 36,929 | $140K |
| Osaic Holdings, Inc. | 0.00% | Add +2781.2% | 30,397 | $115K |
| Meridian Wealth Management, LLC | 0.01% | Add +5.9% | 28,816 | $109K |
| Jain Global LLC | 0.00% | New | 27,679 | $105K |
| Jefferies Financial Group Inc. | 0.00% | No change | 26,000 | $99K |
| World Investment Advisors | 0.00% | Add +17.0% | 25,650 | $97K |
| Balyasny Asset Management L.P. | 0.00% | Add +73.3% | 25,270 | $96K |
| OMERS ADMINISTRATION Corp | 0.00% | Add +8.0% | 24,300 | $92K |
| Dimensional Fund Advisors LP | 0.00% | No change | 19,339 | $73K |
| Marshall Wace, LLP | 0.00% | New | 18,829 | $71K |
| Barclays PLC | 0.00% | Reduce -34.1% | 18,270 | $69K |
| Stonebridge Capital Advisors LLC | 0.01% | No change | 17,500 | $66K |
| Citigroup Inc. | 0.00% | Reduce -56.4% | 16,765 | $64K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -36.8% | 16,483 | $62K |
| Cornerstone Wealth Management, LLC | 0.00% | New | 16,250 | $62K |
| Raymond James Financial Inc. | 0.00% | Add +2.6% | 15,667 | $59K |
| Bank of Montreal | 0.00% | No change | 15,560 | $59K |
| BNP Paribas Financial Markets | 0.00% | Reduce -9.7% | 15,173 | $58K |
| LMR Partners LLP | 0.00% | New | 15,167 | $57K |
| ExodusPoint Capital Management, LP | 0.00% | New | 13,343 | $51K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | Reduce -10.9% | 13,335 | $51K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +0.0% | 13,253 | $50K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 12,480 | $47K |
| Diametric Capital, LP | 0.06% | New | 12,423 | $47K |
| SG Americas Securities, LLC | 0.00% | New | 10,878 | $41K |
| Magnolia Capital Advisors LLC | 0.01% | Reduce -1.6% | 10,000 | $38K |
| MassMutual Private Wealth & Trust, FSB | 0.00% | No change | 4,824 | $18K |
| UBS Group AG | 0.00% | Add +147.7% | 4,382 | $17K |
| US Bancorp \de | 0.00% | No change | 4,335 | $16K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 3,209 | $12K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1,070 | $4K |
| Wells Fargo & Company | 0.00% | New | 1,000 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 738 | $3K |
| Point72 (DIFC) Ltd | 0.00% | New | 642 | $2K |
| Simplex Trading, LLC | 0.00% | New | 374 | $1K |
| Bank of America Corp. | 0.00% | Add +6.7% | 223 | $845 |
| Cornerstone Planning Group LLC | 0.00% | No change | 80 | $317 |
"% of holder's portfolio" is DMAC's weight in each manager's 13F, not the share of Diamedica Therapeutics Inc. the manager owns.